Recent developments in Bangladesh pharma industry

Over the past four decades, the pharmaceutical industry in Bangladesh has undergone a sweeping transformation- emerging from its modest, import-dependent roots into a powerful, innovation-driven sector at the forefront of national development. What once relied heavily on foreign suppliers for basic medicines has now evolved into a self-reliant, technologically advanced industry capable of producing everything from lifesaving generics to complex oncology drugs.

- Dr. Sanjay Agrawal

Today, the pharmaceutical sector is not just a contributor- it is a cornerstone of Bangladesh's economy, accounting for a significant share of the country's GDP, creating thousands of skilled jobs, and establishing a strong footprint in international markets. With over 98 per cent of domestic pharmaceutical demand met locally and exports reaching more than 150 countries, Bangladesh has firmly positioned itself as a rising global pharma hub.

Backed by forward-thinking policies, the development of an Active Pharmaceutical Ingredients (API) industrial park, and a growing reputation for regulatory compliance, the industry's momentum shows no signs of slowing down. As the world increasingly looks for cost-effective, quality drug manufacturing partners, Bangladesh's pharma sector is stepping confidently into the spotlight- sparking the interest of investors, regulators, and healthcare leaders across the globe.

In this context, exploring the recent developments and future prospects of the Bangladesh pharmaceutical industry reveals not just an economic success story, but a national transformation powered by resilience, ambition, and strategic vision.

Current state of industry

Market size and growth

Bangladesh's pharmaceutical market is currently valued at over US$ three billion and continues to grow at an impressive annual rate of 15-17 per cent. By the end of Q1 2025, the domestic market reached US$ 3.03 billion, reflecting a 17.3 per cent year-on-year increase. The sector now contributes approximately 0.65 per cent to Bangladesh's GDP of US$ 467 billion. In local currency, the market has expanded to over BDT 541 billion, underscoring strong underlying growth despite currency devaluation.